Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,201.9
-3.3 (-0.10%)

 

  • STI Straits Times Index
    3,201.9
    -3.3 (-0.10%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,587.9
    -0.1 (-0.01%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,132.0
    5.1 (0.02%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,609.9
    27.3 (0.76%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,600.4
    -204.4 (-0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,625.7
    -18.0 (-0.27%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,220.2M
  • Value: 903.1M
  • Rise: 156
  • Fall: 164
  • Unch: 431

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.063-0.005
Raffles Edu0.063-0.008
Sinjia Land0.100+0.014
Beverly JCG0.001-
Jiutian Chemical0.089+0.002
BHG Retail Reit0.570-
AnAn Intl0.028+0.001
Broadway Ind0.210+0.020
Rex Intl0.360+0.015
VCPlus0.024-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,090.2 -125.5
HSI 26,132.0 +5.1
HSCEI 9,322.1 -34.8
Jakarta 6,625.7 -18.0
Nikkei 225 28,600.4 -204.4
SSE Comp 3,609.9 +27.3
Shanghai A 3,783.3 +28.6
Shanghai B 276.7 +1.0
KOSPI 3,020.5 +14.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UGHealthcare UG HEALTHCARE CORPORATIONLTD
Quotes 10 Minutes Delayed. Updated at 25 Oct 2021 17:04
Last (SGD): 0.340 Change: -0.005 High: 0.350 Remarks: CD
Remarks legend:
RemarksDescriptionRemarksDescription
SuspSuspendedIMMImmediate Delivery
PLPending ListingPAPending Announcement
DLDelistedCTConditional Trading
CWConditional When IssueWIWhen Issue
BIBuyIn OnlyJAdjust
HTrading HaltCDCum Dividend
XDEx DividendCBCum Bonus
XBEx BonusCRCum Rights
XREx RightsCOCum Offer
XOEx OfferCECum Entitlement
XEEx EntitlementCICum Interest
XIEx InterestCACum All
XAEx AllSCScripless Conversion
CIRBCircuit Breaker TriggeredCIRHHalt due to Circuit Breaker Triggered
Change (%): -1.45 Low: 0.340
Open 0.345 Yesterday's Close 0.345
Buy Price 0.340 Sell Price 0.345
Buy Volume ('000) 425.8 Sell Volume ('000) 56.0
Cumulative Volume ('000) 357.5 Cumulative Value 122,841
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.19272 Trailing EPS (SGD) e 0.19272 NAV (SGD) b 0.3093
PE a 1.764 Trailing PE f 1.764 Price / NAV b 1.0993
Dividend (SGD) d 0.005110 Cash In Hand (SGD) g 0.1100 Issued & Paid-up Shares c 616,259,000
Dividend Yield (%) d 1.503 Price / Cash In Hand g 3.091 Treasury Shares h -
Beta - 75 Daysi 1.193 R-Squared - 75 Days(%)i 8.22 Market Cap (M) 209.528
Beta - 500 Daysi 0.040 R-Squared - 500 Days (%)i - Enterprise Value (M) 161.954
Piotroski F Score 7 Exchange Code 8K7 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 54.7679 6-Month VWAP 0.587 Free Float (%) 19.3
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 15 Oct 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UGHealthcare SGX 209.528 1.764 1.764 1.0993 1.503
Industry Medical & Biotechnology SGX 1,022.856 18.917 16.162 1.4406 1.911
Medical Specialties SGX 1,283.217 2.728 2.763 3.1649 20.252
Index FTSE ST Catalist Index SGX 64.009 30.086 23.254 1.4336 1.820
Local Peer Top Glove SGX 7,166.354 2.815 2.815 3.6741 21.200
Local Peer Medtecs Intl SGX 207.636 1.192 1.426 0.8272 17.756
Local Peer Biolidics SGX 52.559 - - 9.9497 -
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 240,756.691 37.766 28.008 6.5327 0.145
Global Peer ABBOTT LABORATORIES NYSE 224,651.750 50.224 31.115 - 1.206
Global Peer DANAHER CORP NYSE 223,934.140 63.799 48.628 -68.5238 0.229
Global Peer MEDTRONIC PLC NYSE 165,655.753 45.939 42.662 3.2175 1.884
Global Peer INTUITIVE SURGICAL INC NASDAQ 121,913.077 114.947 72.172 10.6839 -
Global Peer STRYKER CORP NYSE 103,976.680 65.026 49.917 7.5236 0.852
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,673.812 88.261 49.695 14.1573 -
Global Peer BECTON DICKINSON & CO NYSE 70,961.777 92.518 38.049 2.9404 1.291
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,845.434 - 136.422 4.0049 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,456.725 95.323 76.193 74.1936 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), NOVOCURE LTD (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), GLAUKOS CORPORATION (NYSE), SILK ROAD MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PEIJIA MEDICAL LIMITED (HKEx), AVANOS MEDICAL INC (NYSE), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), KANGJI MEDICAL HLDGS LTD (HKEx), PULMONX CORPORATION (NASDAQ), CUE HEALTH INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PARAGON 28 INC (NYSE), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), SUPERMX (Bursa), ALPHATEC HLDGS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), INOGEN INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), DERMTECH INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), BIOVENTUS INC (NASDAQ), SISRAM MEDICAL LTD (HKEx), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), MODERN DENTAL GROUP LIMITED (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SURMODICS INC (NASDAQ), CUTERA INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), AXOGEN INC (NASDAQ), NYXOAH SA (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), VAPOTHERM INC (NYSE), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), PAVMED INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), SOLITON INC (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), LUCID DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), INCANNEX HEALTHCARE LTD (ASX), CVRX INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), EARGO INC (NASDAQ), AROA BIOSURGERY LTD (ASX), TALIS BIOMEDICAL CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), CONFORMIS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), LUCIRA HEALTH INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), IMPEDIMED LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CORMEDIX INC (NASDAQ), INVACARE CORP (NYSE), INTRICOM CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), KELFRED HOLDINGS LTD (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IRIDEX CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), MICRO-X LTD (ASX), CRYO-CELL INTERNATIONAL INC (NASDAQ), FONAR CORP (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), RGTBHD (Bursa), CLEANSPACE HOLDINGS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OPTISCAN IMAGING (ASX), ENVVENO MED CORP (NASDAQ), ALPHA PRO TECH (NYSE American), SDI LTD (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), BIOLASE INC (NASDAQ), CHECK-CAP LTD (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), LENSAR INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), DIMERIX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), BIOMERICA INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEOVASC INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), APPLIED UV INC (NASDAQ), CARDIEX LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), DAXOR CORP (NYSE American), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), ADVENTA (Bursa), KEWAUNEE SCIENTIFIC CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), NUTRIBAND INC (NASDAQ), RESPIRI LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), LIFE HEALTHCARE GROUP LTD (HKEx), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), NUWELLIS INC (NASDAQ), ADHERIUM LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.005
-1.45 %
20 Days --0.005
-1.45 %
Medium Term Return 3 Months --0.235
-40.87 %
6 Months --0.390
-53.42 %
1 Year 0.003-0.573
-62.43 %
Long Term Return 2 Years 0.006+0.285
+529.09 %
3 Years 0.008+0.270
+397.14 %
5 Years 0.008+0.240
+248.00 %
Annualised Return Annualised --
+28.33 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.315 - 1.008 Change From 1 Year Low +0.025 % Change From 1 Year Low (%) +7.94
Change From 1 Year High -0.668 % Change From 1 Year High (%) -66.28
2 Years Range 0.044 - 1.145 Change From 2 Years Low +0.296 % Change From 2 Years Low (%) +679.82
Change From 2 Years High -0.805 % Change From 2 Years High (%) -70.30
5 Years Range 0.044 - 1.145 Change From 5 Years Low +0.296 % Change From 5 Years Low (%) +679.82
Change From 5 Years High -0.805 % Change From 5 Years High (%) -70.30
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited manufactures and distributes natural latex and nitrile examination gloves. It markets its natural latex and nitrile examination gloves under the Unigloves brand name, as well as under third party labels. The company also distributes ancillary products, such as surgical, vinyl, and cleanroom gloves, as well as face masks and other medical disposables. Its gloves are used in healthcare, food and beverage, and automotive industries. The company markets its products in approximately 50 countries, including Germany, Nigeria, the People's Republic of China, the United States, the United Kingdom, France, Italy, Austria, Switzerland, the Netherlands, Japan, South Korea, Canada, and Brazil. UG Healthcare Corporation Limited was founded in 1989 and is based in Seremban, Malaysia.

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) a 0.072 First Day Close (SGD) a 0.083 First Week Close (SGD) a 0.077
Current vs IPO Price (%) +372.22 First Day Gain (%) +15.28 First Week Gain (%) +6.94
Notes:
  1. Adjusted for the following: Share Split 3 for 1 on 30/09/2020, Special Dividend S$0.00105 on 2/3/2021

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2021 Jun 2021 Part 1(3.58 MB)
Annual Report 2020 Jun 2020 Part 1(3.07 MB)
Annual Report 2019 Jun 2019 Part 1(3.87 MB)
Annual Report 2018 Jun 2018 Part 1(3.37 MB)
Annual Report 2017 Jun 2017 Part 1(1.68 MB)
Part 2(0.17 MB)
Annual Report 2016 Jun 2016 Part 1(3.32 MB)
Annual Report 2015 Jun 2015 Part 1(1.19 MB)
IPO Prospectus
IPO Prospectus 2014 Dec 2014 Part 1(2.18 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
25 Oct 2021 0.345 0.350 0.340 0.340 357,500 0.3436
22 Oct 2021 0.345 0.350 0.340 0.345 984,200 0.3446
21 Oct 2021 0.345 0.350 0.340 0.340 424,400 0.3433
20 Oct 2021 0.340 0.355 0.340 0.345 2,124,400 0.3466
19 Oct 2021 0.345 0.350 0.340 0.350 1,617,700 0.3452
18 Oct 2021 0.340 0.345 0.335 0.340 847,600 0.3400
15 Oct 2021 0.340 0.345 0.335 0.340 1,563,000 0.3402
14 Oct 2021 0.345 0.345 0.335 0.335 1,793,800 0.3402
13 Oct 2021 0.340 0.345 0.335 0.335 1,294,800 0.3388
12 Oct 2021 0.345 0.345 0.335 0.345 1,063,200 0.3399
11 Oct 2021 0.345 0.350 0.340 0.345 1,113,700 0.3447
08 Oct 2021 0.330 0.360 0.330 0.345 5,547,700 0.3464
07 Oct 2021 0.335 0.340 0.330 0.335 3,011,400 0.3343
06 Oct 2021 0.335 0.335 0.325 0.335 1,356,100 0.3310
05 Oct 2021 0.335 0.340 0.325 0.335 1,034,200 0.3338
04 Oct 2021 0.330 0.340 0.325 0.340 2,692,800 0.3324
01 Oct 2021 0.345 0.345 0.330 0.330 2,717,800 0.3356
30 Sep 2021 0.340 0.355 0.335 0.345 3,814,700 0.3463
29 Sep 2021 0.345 0.345 0.340 0.340 1,483,700 0.3418
28 Sep 2021 0.340 0.355 0.340 0.345 2,502,500 0.3505
27 Sep 2021 0.350 0.355 0.340 0.345 2,186,500 0.3440
24 Sep 2021 0.350 0.365 0.345 0.355 4,426,100 0.3520
Summary
Current 2 Weeks
(12 Oct 2021 to 25 Oct 2021)
0.345 0.355 0.335 0.340 12,070,600 -
Previous 2 Weeks
(28 Sep 2021 to 11 Oct 2021)
0.340 0.355 0.335 0.345 25,274,600 -
4 Weeks from
(31 Aug 2021 to 27 Sep 2021)
0.555 0.555 0.335 0.345 68,807,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.